At the pilot sites, PV/LPVs in breast cancer genes were most commonly identified in ATM, BRCA2, and BRCA1, whereas at the non-pilot sites, they were most commonly identified in BRCA2, BRCA1, and PALB2. The gene discussed is BRCA2; the disease is breast carcinoma.